Challenge 1   ➔

YOUR CHALLENGE

Current Delivery Methods Create a Suboptimal Patient Experience and Expensive Total Cost

Current Delivery Methods Create a Suboptimal Patient Experience and Expensive Total Cost

Oncology drugs are evolving rapidly to target specific cells, rather than harming healthy cells to get to the cancer. They’re also evolving to enable patients’ immune systems to be more effective in fighting cancer. But drug delivery technology isn’t changing as quickly.
Oncology drugs are evolving rapidly to target specific cells,
rather than harming healthy cells to get to the cancer. They’re also evolving to enable patients’ immune systems to be more effective in fighting cancer. But drug delivery technology isn’t changing as quickly.
There are Drawbacks to Current Delivery Methods
There are Drawbacks to Current Delivery Methods
Nurse administered delivery ➔
Some companies are developing oncology drugs for SC injection using a syringe, which often requires a nurse for administration . While SC injections can help with reducing chair time, large volumes via syringe are painful for the patient.
Negative feedback ➔
Companies that develop new drugs with traditional or sub-optimal delivery methods may disappoint patients and caregivers. Because of this, Patient-Focused Drug Development (PFDD), is gaining increasing importance in the regulatory process.
Cost & limitations ➔
And, with continued reliance on infusion center-based treatments, SC injection will allow you to treat more patients in a 24-hour period than via infusion .

THE SOLUTION:


Improve the patient experience by how the treatment is delivered

IV- and some syringe-based oncology treatments must be administered in infusion chairs, which is expensive and does not deliver an optimal patient experience. With West Pharmaceutical Services, Inc. (West), you can expand patient access to SC delivery via a large-volume device that attaches to the patient and moves the patient out of the infusion chair.

THE SOLUTION:


Improve the Treatment by How It’s Delivered

IV- and some syringe-based oncology treatments must be administered in infusion chairs, which is expensive and does not deliver an optimal patient experience. With West Pharmaceutical Services, Inc. (West), you can expand patient access to SC delivery via a large-volume device that attaches to the patient and moves the patient out of the infusion chair.

Deliver your drug effectively via a more patient-friendly system

Improve the patient experience without sacrificing care with a discreet wearable device that supports large-volume delivery

Learn more: westpharma.com/oncology

Learn more: westpharma.com/smartdose